Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on MDxHealth SA (MDXH)

August 23, 2024 5:05 AM
BTIG analyst Mark Massaro reiterated a Buy rating and $8.00 price target on MDxHealth SA (NASDAQ: MDXH)The analyst comments "As ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles